Indo Borax Acquires Majority Stake in Kronox Lab Sciences

Indo Borax & Chemicals Limited will acquire 64.26% of Kronox Lab Sciences Limited for Rs 246.12 crore.

Reader Takeaway: Diversifies business into specialty chemicals; contingent open offer adds complexity.

What just happened

Indo Borax & Chemicals Limited's board has approved the acquisition of a majority 64.26% stake in Kronox Lab Sciences Limited. The company will purchase 2,38,44,000 equity shares at Rs 103.22 per share, totaling Rs 246.12 crore. Following this acquisition, Indo Borax will also launch a mandatory open offer to acquire up to 25.79% of Kronox Lab's shares at Rs 157.27 per share, as per SEBI (SAST) Regulations.

A share purchase agreement has been executed with the promoters of Kronox Lab Sciences, including Mr. Ketan Vinodchandra Ramani, Mr. Pritesh Vinodchandra Ramani, and Mr. Jogindersingh Gianchand Jaswal. The effective acquisition price, including consultancy fees, is Rs 105.87 per share.

Why this matters

This acquisition marks a significant diversification for Indo Borax & Chemicals into the high-purity specialty fine chemicals manufacturing sector. It aligns with the company's long-term strategy to invest in stable, growth-potential sectors and expand its business portfolio.

The backstory

Kronox Lab Sciences Limited is involved in manufacturing high-purity specialty fine chemicals. Its turnover has shown growth, reaching Rs 89.86 crore in FY 2023-24 and projected to exceed Rs 100 crore in FY 2025-26.

What changes now

Indo Borax & Chemicals will gain control over Kronox Lab Sciences, integrating its operations into its business. Shareholders should monitor the open offer process and the subsequent performance of the combined entity.

Risks to watch

Key risks include the successful completion of the mandatory open offer and the integration of Kronox Lab Sciences into Indo Borax's existing operations. Potential volatility in specialty chemical markets could also impact performance.

Peer comparison

While direct peer comparison data is not provided in the filing, Kronox Lab Sciences operates in the specialty chemicals segment, a sector with several established Indian players and growing global demand.

Context metrics (time-bound)

Kronox Lab Sciences reported a turnover of Rs 89.86 crore in FY 2023-24, with projected turnover of Rs 1,00,19,39,040 for FY 2024-25 and Rs 1,01,21,98,447 for FY 2025-26.

What to track next

Investors will be looking for updates on the open offer timeline and subscription levels, as well as the company's strategy for synergy realization and growth within the specialty chemicals domain.